Johnson & Johnson (JNJ)

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide.

If you are interested in JNJ stock information, you might also be interested in competitors like XTRA:BAYN.

With a P/E ratio of 15.00, the stock appears relatively cheap compared to its index ^SPX at the moment.

The market capitalization of Johnson & Johnson is currently at $434.60 B. This places it among the high capitalized companies.

The book value reported in the balance sheet results in a P/B ratio of 5.69.

With one share of Johnson & Johnson investors achieved a dividend of $4.51. This results in a good dividend yield of 2.73%. In the last 22 years, the quarterly dividend has risen constantly.

For the risk analysis, the low beta factor should be noted, which is currently at a value of 0.59. The price of the stock NYSE:JNJ is therefore subject to moderate fluctuations in relation to the overall market.

0.13% of JNJ Stocks is owned by insiders.

For Wall Street analysts, a price target of $186.00 is currently considered realistic.

NYSE:JNJ has a 52 week range of $155.72 - $186.69 and is currently trading around $165.30.

The low short sale ratio indicated that the value might increase in the foreseeable future.